
    
      A Single-Center, Randomized, Double-Blinded, Placebo-Controlled, 4-way Cross-over Study to
      Assess the Effect of a Single Oral Dose of AZD3293 Administration on QTc Interval Compared to
      Placebo, Using Open-Label AVELOX (moxifloxacin) as a Positive Control, in Healthy Male
      Subjects
    
  